Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Klein, S. Moss, R. Klein, T. Surawicz (1991)
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate.Ophthalmology, 98 8
M. Nishimura, T. Tanaka, T. Yasuda, S. Kurakata, M. Kitagawa, K. Yamada, Y. Saito, A. Hirai (1999)
Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.Kidney international. Supplement, 71
B. Guerci, B. Igau, O. Ziegler, T. Crea, J. Fruchart, P. Drouin, C. Fiévet (1994)
Lack of relationship between Lp(a) particle levels and albumin excretion rate in type 1 diabetic patients.Diabete & metabolisme, 20 6
A. Tonkin, P. Alyward, D. Colquhoun, P. Glasziou, P. Harris, D. Hunt, A. Keech, S. MacMahon, P. Magnus, D. Newel, P. Nestel, N. Sharpe, J. Shaw, R. Simes, P. Thompson, A. Thompson, M. West, H. White, S. Simes, W. Hague, S. Caleo, Jane Hall, Andrew Martin, S. Mulray, P. Barter, L. Beilin, R. Collins, J. McNeil, P. Meier, H. Willimott, D. Smithers, P. Wallace, J. Baker, M. Hobbs, D. Sullivan, N. Anderson, G. Hankey, J. Watson, M. Arulchelvam, S. Chup, J. Daly, J. Hanna, A. Leach, M. Lee, J. Loughhead, H. Lundie-Jenkin, J. Morrison, S. Netting, A. Nguyen, H. Pater, R. Philip, G. Pinna, D. Rattos, S. Ryerson, V. Sazhin, R. Walsh, A. Claque, M. Mackie, J. Yallop, K. Boss, M. Shepard, J. Leach, M. Gandy, J. Joughin, J. Seabrook, R. Abraham, J. Allen, F. Bates, I. Beinart, E. Breed, D. Brown, N. Bunyan, D. Calvert, T. Campbell, D. Condon‐Paoloni, B. Conway, L. Coupland, J. Crowe, N. Cunio, B. Cuthbert, N. Cuthbert, S. D'arcy, P. Davidson, B. Dwyer, J. England, C. Friend, G. Fulcher, S. Grant, K. Hellestrand, M. Kava, L. Kritharides, D. McGill, H. McKee, A. Mclean, M. Neaverson, G. Nelson, M. O'Neill, C. Onuma, F. O'Reilly (1998)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.The New England journal of medicine, 339 19
Y. Kureishi, Zhengyu Luo, Ichiro Shiojima, Anna Bialik, D. Fulton, D. Lefer, W. Sessa, Kenneth Walsh (2000)
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 6
M. Martínez-Triguero, Antonio Salvador, Maria-José Samper, Manuel Almela, L. Vega, Antonio Mora, Vicente Martínez-Diago (1994)
Lipoprotein (a) and other risk factors in patients with non‐insulin-dependent diabetes mellitusCoronary Artery Disease, 5
Chulhyun Kim, H. Park, J. Park, S. Hong, Y. Yoon, Ki-Up Lee (1998)
High Serum Lipoprotein(a) Levels in Korean Type 2 Diabetic Patients With Proliferative Diabetic RetinopathyDiabetes Care, 21
F. Vrtovsnik, M. Essig, O. Iimura, G. Friedlander (1999)
Effect of lipid-lowering strategies on tubular cell biology.Kidney international. Supplement, 71
J. Downs, M. Clearfield, S. Weis, E. Whitney, D. Shapiro, P. Beere, A. Langendorfer, E. Stein, W. Kruyer, A. Gotto (1998)
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.JAMA, 279 20
D. Mouton, A. Gill (1988)
Prevalence of diabetic retinopathy and evaluation of risk factors. A review of 1,005 diabetic clinic patients.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 74 8
R. Miccoli, G. Odello, O. Giampietro, P. Marchetti, R. Cristofani, G. Penno, G. Meucci, R. Navalesi (1987)
Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus.Ophthalmic research, 19 1
B. Rovin, L. Tan (1993)
LDL stimulates mesangial fibronectin production and chemoattractant expression.Kidney international, 43 1
Linda Fried, Kimberly Forrest, D. Ellis, Yuefang Chang, N. Silvers, Trevor Orchard (2001)
Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes.Journal of diabetes and its complications, 15 3
Sonia Anand, E. Enas, J. Pogue, S. Haffner, T. Pearson, S. Yusuf (1998)
Elevated lipoprotein(a) levels in South Asians in North America.Metabolism: clinical and experimental, 47 2
T. Quaschning, M. Schömig, M. Keller, J. Thiery, M. Nauck, P. Schollmeyer, C. Wanner, A. Krämer-Guth (1999)
Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients.Journal of the American Society of Nephrology : JASN, 10 2
Cathy Lloyd, Ronald Klein, R. Maser, Lewis Kuller, D. Becker, Trevor Orchard (1995)
The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.Journal of diabetes and its complications, 9 3
M. Mackinnon (1990)
Diabetes care in general practice.Nursing standard (Royal College of Nursing (Great Britain) : 1987), 5 3
H. Hammes, A. Weiss, D. Führer, H. Krämer, C. Papavassilis, F. Grimminger (1996)
Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acidsDiabetologia, 39
B. Harrold, V. Marmion, K. Gough (1969)
A Double-blind Controlled Trial of Clofibrate in the Treatment of Diabetic RetinopathyDiabetes, 18
A. Krolewski, J. Warram, A. Christlieb (1994)
Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy.Kidney international. Supplement, 45
Leo Niskanen, M. Uusitupa, H. Sarlund, O. Siitonen, E. Voutilainen, I. Penttilä, K. Pyörälä (1990)
Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 33
Samy McFarlane, R. Muniyappa, R. Francisco, J. Sowers (2002)
Pleiotropic Effects of Statins: Lipid Reduction and BeyondThe Journal of Clinical Endocrinology and Metabolism, 87
A. Sjølie, J. Stephenson, Stephen Aldington, E. Kohner, H. Janka, L. Stevens, J. Fuller (1997)
Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.Ophthalmology, 104 2
Tatsuya Suzuki, K. Oba, Y. Igari, N. Matsumura, Y. Inuzuka, Y. Kigawa, Y. Matsuura, Y. Ajiro, K. Okazaki, H. Nakano (2002)
Relation of apolipoprotein (a) phenotypes to diabetic retinopathy in elderly type 2 diabetes.Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 69 1
Joon-Keun Park, Dominik Müller, E. Mervaala, R. Dechend, A. Fiebeler, F. Schmidt, M. Bieringer, Olaf Schäfer, C. Lindschau, Wolfgang Schneider, Detlev Ganten, Friedrich Luft, Hermann Haller (2000)
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.Kidney international, 58 4
L. Westerhuis, W. Venekamp (1996)
Serum lipoprotein-a levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus.Clinical biochemistry, 29 3
N. Abdella, O. Mojiminiyi, A. Akanji, H. Mohammadi, M. Moussa (2001)
Serum lipoprotein(a) concentration as a cardiovascular risk factor in Kuwaiti type 2 diabetic patients.Journal of diabetes and its complications, 15 5
F. Vrtovsnik, F. Vrtovsnik, S. Couette, S. Couette, D. Prié, D. Prié, D. Lallemand, D. Lallemand, G. Friedlander, G. Friedlander (1997)
Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway.Kidney international, 52 4
T. Dornan, R. Carter, A. Bron, R. Turner, J. Mann (1982)
Low density lipoprotein cholesterol: An association with the severity of diabetic retinopathyDiabetologia, 22
O. Vaccaro, A. Perna, F. Mancini, C. Iovine, Cuomo, M. Sacco, A. Tufano, A. Rivellese, D. Ingrosso, G. Riccardi (2000)
Plasma homocysteine and microvascular complications in type 1 diabetes.Nutrition, metabolism, and cardiovascular diseases : NMCD, 10 6
S. Grundy, I. Benjamin, G. Burke, A. Chait, R. Eckel, B. Howard, W. Mitch, S. Smith, J. Sowers (1999)
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.Circulation, 100 10
K. Forrest, R. Maser, G. Pambianco, D. Becker, T. Orchard (1997)
Hypertension as a Risk Factor for Diabetic Neuropathy: A Prospective StudyDiabetes, 46
R. Klein, B. Klein, S. Moss, M. Davis, D. DeMets (1987)
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation.Ophthalmology, 94 7
G. Marshall, Satish Garg, William Jackson, Douglas Holmes, H. Chase (1993)
Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus.Ophthalmology, 100 8
M. Sarnak, Andrew Levey (2000)
Epidemiology, Diagnosis, and Management of Cardiac Disease in Chronic Renal DiseaseJournal of Thrombosis and Thrombolysis, 10
Robert Cohen, C. Hennekens, W. Christen, A. Krolewski, D. Nathan, Michael Peterson, F. LaMotte, J. Manson (1999)
Determinants of retinopathy progression in type 1 diabetes mellitus.The American journal of medicine, 107 1
Dr. Parving, Dr. Lam (1995)
Cholesterol-lowering therapy may retard the progression of diabetic nephropathyDiabetologia, 39
A. Bostom, L. Cupples, J. Jenner, J. Ordovás, L. Seman, P. Wilson, E. Schaefer, W. Castelli (1996)
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.JAMA, 276 7
B. Kasiske, M. O'Donnell, M. Cleary, W. Keane (1988)
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.Kidney international, 33 3
T. Sakurai, H. Akiyama, T. Oka, K. Sekita, K. Yokono, T. Goto (1999)
Serum lipids status in patients with diabetic uremia on 10 years of maintenance hemodialysis.Kidney international. Supplement, 71
P. Hovind, P. Rossing, L. Tarnow, U. Smidt, H. Parving (2001)
Progression of diabetic nephropathy.Kidney international, 59 2
Sung Kim, D. Han, Hi Lee (2000)
Lovastatin Inhibits Transforming Growth Factor-b 1 Expression in Diabetic Rat Glomeruli and Cultured Rat Mesangial Cells
W. Eck (1959)
The effect of a low fat diet on the serum lipids in diabetes and its significance in diabetic retinopathy.The American Journal of Medicine, 27
C. Hernández, P. Chacón, R. Martí, L. García-Pascual, J. Mesa, R. Simó (2000)
Relationship of Lipoprotein(a) and Its Phenotypes with the Albumin Excretion Rate in Diabetic Patients: A Multivariate AnalysisNephron, 85
D. Willems, D. Dufrasne, H. Dorchy (1996)
Serum lipoprotein (a) in type 1 diabetic children and adolescents: Relationships with HbA1c and subclinical complicationsEuropean Journal of Pediatrics, 155
L. Tarnow, P. Rossing, F. Nielsen, B. Hansen, J. Dyerberg, H. Parving (1996)
Increased Plasma Apolipoprotein(a) Levels in IDDM Patients With Diabetic NephropathyDiabetes Care, 19
S. Jones, C. Close, M. Mattock, R. Jarrett, H. Keen, G. Viberti (1989)
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.British Medical Journal, 298
B. Heesen, B. Wolffenbuttel, P. Leurs, J. Sels, P. Menheere, S. JÄCKLE‐BECKERS, A. Kruseman (1993)
Lipoprotein(a) levels in relation to diabetic complications in patients with non‐insuIin‐dependent diabetesEuropean Journal of Clinical Investigation, 23
R. King, J. Dobree, D. Kok, W. Foulds, W. Dangerfield (1963)
EXUDATIVE DIABETIC RETINOPATHY SPONTANEOUS CHANGES AND EFFECTS OF A CORN OIL DIET*British Journal of Ophthalmology, 47
T. Hirano (1999)
Lipoprotein abnormalities in diabetic nephropathy.Kidney international. Supplement, 71
M. Gall, P. Rossing, E. Hommel, A. Voldsgaard, P. Andersen, F. Nielsen, J. Dyerberg, H. Parving (1992)
Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy.Scandinavian journal of clinical and laboratory investigation, 52 6
L. Duncan, J. Cullen, J. Ireland, J. Nolan, B. Clarke, M. Oliver (1968)
A Three-Year Trial of Atromid Therapy in Exudative Diabetic RetinopathyDiabetes, 17
F. Sacks, M. Pfeffer, L. Moye, J. Rouleau, J. Rutherford, T. Cole, L. Brown, J. Warnica, J. Arnold, C. Wun, B. Davis, E. Braunwald (1996)
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.The New England journal of medicine, 335 14
Y. Smulders, A. Eeden, C. Stehouwer, R. Weijers, E. Slaats, J. Silberbusch (1997)
Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non‐insulin‐dependent diabetes mellitus?European Journal of Clinical Investigation, 27
B. Kremser, M. Falk, G. Kieselbach (1995)
Influence of serum lipid fractions on the course of diabetic macular edema after photocoagulation.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 209 2
K. Sen, Anoop Misra, Atul Kumar, R. Pandey (2002)
Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia.Diabetes research and clinical practice, 56 1
P. Groop, G. Viberti, T. Elliott, R. Friedman, A. Mackie, C. Ehnholm, M. Jauhiainen, M. Taskinen (1994)
Lipoprotein(a) in Type 1 Diabetic Patients with Renal DiseaseDiabetic Medicine, 11
Margarete Goppelt-Struebe, A. Hahn, D. Iwanciw, M. Rehm, B. Banas (2001)
Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins)Molecular Pathology, 54
A. Verrotti, L. Lobefalo, F. Chiarelli, L. Mastropasqua, R. Pallotta, L. Colangelo, G. Morgese, P. Gallenga (1997)
Lipids and lipoproteins in diabetic adolescents and young adults with retinopathyEye, 11
S. Nielsen, O. Schmitz, N. Moller (1993)
Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuriaDiabetologia, 36
K. Pyôrâlà, T. Pedersen, J. Kjekshus, O. Faergeman, A. Olsson, G. Thorgeirsson (1997)
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)Diabetes Care, 20
H. Mulec, S. Johnsen, O. Wiklund, Staffan Björck (1993)
Cholesterol: a renal risk factor in diabetic nephropathy?American journal of kidney diseases : the official journal of the National Kidney Foundation, 22 1
S. Dithmar, C. Curcio, N. Le, S. Brown, H. Grossniklaus (2000)
Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice.Investigative ophthalmology & visual science, 41 8
P. Winocour, D. Bhatnagar, M. Ishola, S. Arrol, P. Durrington (1991)
Lipoprotein (a) and Microvascular Disease in Type 1 (Insulin‐dependent) DiabetesDiabetic Medicine, 8
E. Hommel, P. Andersen, M.A. Gall (1992)
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathyDiabetologia, 35
T. Orchard, J. Dorman, R. Maser, D. Becker, D. Ellis, R. LaPorte, L. Kuller, S. Wolfson, A. Drash (1990)
Factors Associated With Avoidance of Severe Complications After 25 Yr of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study IDiabetes Care, 13
J. Reverter, E. Pizarro, M. Sentí, J. Pedro-botet, J. Rubiés-prat, R. Romero, A. Lucas, A. Sanmartí, Isabel Saunas (1994)
Relationship Between Lineprotein Profile and Urinary Albumin Excretion in Type II Diabetic Patients With Stable Metabolic ControlDiabetes Care, 17
A. Houtsmuller (1968)
Treatment of exudative diabetic retinopathy with atromid-S.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 156 1
P. Vannini, A. Ciavarella, M. Flammini, A. Bargossi, G. Forlani, Luigi Borgnino, G. Orsoni (1984)
Lipid Abnormalities in Insulin-dependent Diabetic Patients with AlbuminuriaDiabetes Care, 7
H. Rubins, S. Robins, D. Collins, C. Fye, James Anderson, M. Elam, F. Faas, E. Linares, E. Schaefer, G. Schectman, T. Wilt, J. Wittes (1999)
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.The New England journal of medicine, 341 6
K. Harris, M. Purkerson, J. Yates, S. Klahr (1990)
Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome.American journal of kidney diseases : the official journal of the National Kidney Foundation, 15 1
K. Luthra, Anoop Misra, L. Srivastava (1999)
LIPOPROTEIN (A) : BIOLOGY AND ROLE IN ATHEROSCLEROTIC VASCULAR DISEASESCurrent Science, 76
P. Lip, A. Jones, N. Price, M. Headon, D. Beevers, G. Lip (1998)
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?Acta ophthalmologica Scandinavica, 76 5
S. Soedamah-Muthu, H. Colhoun, M. Taskinen, B. Idzior-Waluś, J. Fuller, T. Group (2000)
Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patientsDiabetologia, 43
S. Hadjadj, Y. Gallois, G. Simard, B. Bouhanick, P. Passa, A. Grímaldi, P. Drouin, J. Tichet, M. Marre (2000)
Lack of relationship in long‐term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein ε, lipoprotein lipase and cholesteryl ester transfer proteinNephrology Dialysis Transplantation, 15
Glancarlo Tonolo, M. Ciccarese, P. Brizzi, L. Puddu, G. Secchi, P. Calvia, M. Atzeni, M. Melis, M. Maioli (1997)
Reduction of Albumin Excretion Rate in Normotensive Microalbuminuric Type 2 Diabetic Patients During Long-Term Simvastatin TreatmentDiabetes Care, 20
T. Nagai, T. Tomizawa, K. Nakajima, M. Mori (2000)
Effect of bezafibrate or pravastatin on serum lipid levels and albuminuria in NIDDM patients.Journal of atherosclerosis and thrombosis, 7 2
L. Larsson, A. Alm, F. Lithner, G. Dahlén, R. Bergström (1999)
The association of hyperlipidemia with retinopathy in diabetic patients aged 15-50 years in the county of Umeå.Acta ophthalmologica Scandinavica, 77 5
L. Fried, L. Fried, T. Orchard, T. Orchard, B. Kasiske, B. Kasiske (2001)
Effect of lipid reduction on the progression of renal disease: a meta-analysis.Kidney international, 59 1
B. Howard, M. Magee (2000)
Diabetes and cardiovascular diseaseCurrent Atherosclerosis Reports, 2
O. Hernández-Perera, D. Pérez-Sala, J. Navarro-Antolín, R. Sánchez-Pascuala, G. Hérnandez, Cristina Díaz, S. Lamas (1998)
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.The Journal of clinical investigation, 101 12
H. Asakawa, K. Tokunaga, F. Kawakami (2000)
Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.Journal of diabetes and its complications, 14 3
R. Goldberg, M. Mellies, F. Sacks, L. Moye, B. Howard, W. Howard, B. Davis, T. Cole, M. Pfeffer, E. Braunwald (1998)
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.Circulation, 98 23
H. Freyberger, E. Schifferdecker, H. Schatz (1994)
[Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].Medizinische Klinik, 89 11
M. Clodi, R. Oberbauer, G. Bodlaj, J. Hofmann, G. Maurer, K. Kostner (1999)
Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.Metabolism: clinical and experimental, 48 3
G. Rhoads, G. Dahlén, K. Berg, N. Morton, A. Dannenberg (1986)
Lp(a) lipoprotein as a risk factor for myocardial infarction.JAMA, 256 18
C. Agardh, E. Agardh, B. Bauer, P. Nilsson‐Ehle (2009)
Plasma lipids and plasma lipoproteins in diabetics with and without proliferative retinopathy.Acta medica Scandinavica, 223 2
J. Cullen, J. Ireland, M. Oliver (1964)
A controlled trial of Atromid therapy in exudative diabetic retinopathy.Transactions of the ophthalmological societies of the United Kingdom, 84
Paul Hopkins, Lily Wu, Steven Hunt, Brent James, G. Vincent, Roger Williams (1997)
Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease.Arteriosclerosis, thrombosis, and vascular biology, 17 11
B. Guerci, L. Meyer, S. Sommer, J. George, O. Ziegler, P. Drouin, K. Angioï-Duprez (1999)
Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.Diabetes & metabolism, 25 5
R. James, M. Boemi, C. Sirolla, L. Amadio, P. Fumelli, D. Pometta (1995)
Lipoprotein (a) and vascular disease in diabetic patientsDiabetologia, 38
B. Kasiske, M. O'Donnell, P. Schmitz, Y. Kim, W. Keane (1990)
Renal injury of diet-induced hypercholesterolemia in rats.Kidney international, 37 3
R. Eckel, E. McLean, J. Albers, M. Cheung, E. Bierman (1981)
Plasma Lipids and Microangiopathy in Insulin-dependent Diabetes MellitusDiabetes Care, 4
G. Yoshino, T. Hirano, T. Kazumi (2002)
Atherogenic lipoproteins and diabetes mellitus.Journal of diabetes and its complications, 16 1
P. Janknecht, M. Schumann, Lutz Hansen (1996)
Reduction of Retinal Exudates in Diabetic Retinopathy after Heparin-Induced Extracorporal Ldl-Precipitation (Help). A Case ReportEuropean Journal of Ophthalmology, 6
M. Ritter, M. Loscar, W. Richter, P. Schwandt (1993)
Lipoprotein(a) in diabetes mellitus.Clinica chimica acta; international journal of clinical chemistry, 214 1
B. Weber, W. Burger, R. Hartmann (1986)
Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitusDiabetologia, 29
T. Onuma, T. Kikuchi, M. Shimura, M. Tsutsui, J. Matsui, A. Boku, K. Takebe (1994)
Lipoprotein(a) as an independent risk factor for diabetic retinopathy in male patients in non-insulin-dependent diabetes mellitus.The Tohoku journal of experimental medicine, 173 2
K. Pyörälä, M. Laakso, M. Uusitupa (1987)
Diabetes and atherosclerosis: an epidemiologic view.Diabetes/metabolism reviews, 3 2
T. Jensen, K. Borch-Johnsen, A. Kofoed‐Enevoldsen, Torsten Deckert (1987)
Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factorsDiabetologia, 30
Z. Massy, Youngki Kim, C. Guijarro, B. Kasiske, W. Keane, M. O'Donnell (2000)
Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.Biochemical and biophysical research communications, 267 2
F. Kronenberg, G. Utermann, H. Dieplinger (1996)
Lipoprotein(a) in renal disease.American journal of kidney diseases : the official journal of the National Kidney Foundation, 27 1
S. Hadjadj, Y. Gallois, G. Simard (2000)
Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genetique de la Nephropathie Diabetique Study Group. Donnees Epidemiologiques sur le Syndrome d’Insulino-Resistance Study GroupNephrol Dial Transplant, 15
J. Kostraba, R. Klein, J. Dorman, D. Becker, A. Drash, R. Maser, T. Orchard (1991)
The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy.American journal of epidemiology, 133 4
B. Coonrod, D. Ellis, D. Becker, C. Bunker, S. Kelsey, C. Lloyd, A. Drash, L. Kuller, T. Orchard (1993)
Predictors of Microalbuminuria in Individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications StudyDiabetes Care, 16
R. Hoogeveen, J. Gambhir, D. Gambhir, K. Kimball, Karima Ghazzaly, J. Gaubatz, Meena Vaduganathan, Rohini Rao, M. Koschinsky, J. Morrisett (2001)
Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.Journal of lipid research, 42 4
P. Koskinen, M. Mänttäri, V. Manninen, J. Huttunen, O. Heinonen, M. Frick (1992)
Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart StudyDiabetes Care, 15
H. Colhoun, E. Lee, P. Bennett, M. Lu, H. Keen, S.-L. Wang, L. Stevens, J. Fuller, A. Group (2001)
Risk factors for renal failure: The WHO multinational study of vascular disease in diabetesDiabetologia, 44
R. Maser, David Usher, D. Becker, A. Drash, L. Kuller, T. Orchard (1993)
Lipoprotein(a) Concentration Shows Little Relationship to IDDM Complications in the Pittsburgh Epidemiology of Diabetes Complications Study CohortDiabetes Care, 16
J. Moorhead, M. El-Nahas, M. Chan, Z. Varghese (1982)
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASEThe Lancet, 320
H. Nakagawa, Y. Kida, K. Sakamoto, M. Haneda, R. Kikkawa (1996)
[Relationship between the stage of diabetic nephropathy and serum lipoprotein (a) concentrations--influence of hypoproteinemia].Nihon Jinzo Gakkai shi, 38 11
A. Kissebah, E. Kohner, B. Lewis, Y. Siddiq, C. Lowy, T. Fraser (1975)
PLASMA-LIPIDS AND GLUCOSE/INSULIN RELATIONSHIP IN NON-INSULIN-REQUIRING DIABETICS WITH AND WITHOUT RETINOPATHYThe Lancet, 305
R. Widder, R. Brunner, P. Walter, C. Lüke, K. Bartz-Schmidt, K. Heimann, H. Borberg (1999)
Improvement of visual acuity in patients suffering from diabetic retinopathy after membrane differential filtration: a pilot study.Transfusion science, 21 3
K. Jandeleit-Dahm, Z. Cao, A. Cox, Darren Kelly, Richard Gilbert, Mark Cooper (1999)
Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy.Kidney international. Supplement, 71
J. Murakami, K. Kumasaka, K. Kawano, T. Murakami, Y. Hayashi, Y. Arakawa (1994)
[Lp(a) serum concentrations in diabetes mellitus].Rinsho byori. The Japanese journal of clinical pathology, 42 12
C. Mogensen (1998)
Natural history of cardiovascular and renal disease in patients with type 2 diabetes: effect of therapeutic interventions and risk modification.The American journal of cardiology, 82 9B
Hiroaki Oda, William Keane (1999)
Recent advances in statins and the kidney.Kidney international. Supplement, 71
E. Chew, M. Klein, Frederick Ferris, N. Remaley, R. Murphy, K. Chantry, B. Hoogwerf, Dayton Miller (1996)
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.Archives of ophthalmology, 114 9
M. Boemi, C. Sirolla, P. Fumelli, R. James (1999)
Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients.Diabetes care, 22 12
K. West, L. Erdreich, J. Stober (1980)
A Detailed Study of Risk Factors for Retinopathy and Nephropathy in DiabetesDiabetes, 29
K.S. Lam, R.W. Pang, M.S. Wat (1996)
Apolipoprotein (a) levels and phenotypes in NIDDM patients with microalbuminuria and albuminuriaNephrol Dial Transplant, 11
Demetrius Ellis, Cathy Lloyd, D. Becker, Kimberly Forrest, Trevor Orchard (1996)
The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.American journal of kidney diseases : the official journal of the National Kidney Foundation, 27 6
O. Kordonouri, T. Danne, Werner Hopfenmüller, I. Enders, G. Hövener, Bruno Weber (1996)
Lipid profiles and blood pressure: are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin‐dependent diabetes mellitus?Acta Pædiatrica, 85
(1975)
7 – Serum Lipoproteins
T. Takemura, K. Yoshioka, K. Yoshioka, N. Aya, N. Aya, K. Murakami, K. Murakami, Akiyo Matumoto, Akiyo Matumoto, H. Itakura, H. Itakura, Tatsuhiko Kodama, Tatsuhiko Kodama, H. Suzuki, Hiroshi Suzuki, S. Maki, S. Maki (1993)
Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases.Kidney international, 43 4
M. Kawamura, J. Heinecke, A. Chait (1994)
Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.The Journal of clinical investigation, 94 2
B. Gordon, M. Kavanagh, C. Robertson, A. Drexler, Stanley Chang, M. Berrocal, L. Yannuzzi (1991)
The effects of lipid lowering on diabetic retinopathy.American journal of ophthalmology, 112 4
M. Clodi, R. Oberbauer, W. Waldhäusl, G. Maurer, G. Kostner, K. Kostner (1997)
Urinary excretion of apo(a) fragments in NIDDM patientsDiabetologia, 40
N. Morisaki, K. Yokote, J. Tashiro, Hidekuni Inadera, Junji Kobayashi, T. Kanzaki, Y. Saito, S. Yoshida (1994)
Lipoprotein(a) Is a Risk Factor for Diabetic Retinopathy in the ElderlyJournal of the American Geriatrics Society, 42
J. Breyer, R. Bain, Joni Evans, N. Nahman, E. Lewis, Melisa Cooper, J. McGill, T. Berl (1996)
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group.Kidney international, 50 5
K. Lam, Richard Pang, M. Wat, Ian Lauder, Edward Janus, K. Lam (2005)
NephrologyDialysis Transplantation Apolipoprotein (a) levels and phenotypes in NIDDM patients with microalbuminuria and albuminuria
F. Olivarius Nde, A.H. Andreasen, N. Keiding (1993)
Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients: cross-sectional data from the population-based study “Diabetes Care in General Practice”, DenmarkDiabetologia, 36
Y. Smulders, M. Rakic, C. Stehouwer, R. Weijers, E. Slaats, J. Silberbusch (1997)
Determinants of Progression of Microalbuminuria in Patients With NIDDM: A prospective studyDiabetes Care, 20
P. Ebeling, V. Koivisto (1997)
Occurrence and interrelationships of complications in insulin-dependent diabetes in FinlandActa Diabetologica, 34
M. Berenyi, B. Straus, Osvaldo Miglietta (1971)
TREATMENT OF DIABETIC NEUROPATHY WITH CLOFIBRATEJournal of the American Geriatrics Society, 19
Enas Ea, J. Dhawan, S. Petkar (1997)
Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein(a).Indian heart journal, 49 1
(2001)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 285
Dyslipidemia is a major factor responsible for coronary heart disease and its reduction decreases coronary risk in patients with diabetes mellitus. However, the association of dyslipidemia with microvascular complications and the effect of intervention with lipid-lowering therapy in diabetes have been less investigated. We present the systematic review of association and intervention studies pertaining to dyslipidemia and microvascular disease in diabetes and also review possible mechanisms. Dyslipidemia may cause or exacerbate diabetic retinopathy and nephropathy by alterations in the coagulation-fibrinolytic system, changes in membrane permeability, damage to endothelial cells and increased atherosclerosis. Hyperlipidemia is associated with faster decline in glomerular filtration rate and progression of albuminuria and nephropathy. Recent evidence also suggests a role of lipoprotein(a) in progression of retinopathy and nephropathy in patients with diabetes mellitus. Lipid-lowering therapy, using single agents or a combination of drugs may significantly benefit diabetic retinopathy and diabetic nephropathy. In particular, hydroxymethyl glutaryl coenzyme A reductase inhibitors may be effective in preventing or retarding the progression of microvascular complications because of their powerful lipid-lowering effects and other additional mechanisms. However, most of the data are based on short-term studies, and need to be ascertained in long-term studies. Until more specific guidelines are available, aggressive management of diabetic dyslipidemia, according to currently accepted guidelines, should be continued for the prevention of macrovascular disease which would also benefit microvascular complications.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Sep 11, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.